CorMedix CRMD 深 沪
等待开盘 09-30 09:30:00 美东时间
7.93
+0.040
+0.51%
华盛通- 最 高7.96
- 今 开7.91
- 成交量 81.74万股
- 最 低 7.82
- 昨 收 7.89
- 总市值 6.18亿
- 52周最高 13.02
- 市盈率 静 3.91
- 换手率 1.05%
- 52周最低 6.125
- 委 比 96.40%
- 总股本 7794.43万
- 历史最高 52.00
- 量 比 1.12
- 振 幅 1.77%
- 历史最低 0.73
- 每 手 1
- 风险率 1.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 汽车地带绩后遭10家机构降目标价！最低看至3000美元；美光、微软、Meta齐获看多
今日重点评级关注：Leerink Partners：维持塞德斯医疗"跑赢大市"评级，目标价从70美元升至88美元；HC Wainwright & Co.：维持TriSalus Life Sciences"买入"评级，目标价从11美元升至12美元
09-24 16:10
Oppenheimer Initiates Coverage On Cormedix with Outperform Rating, Announces Price Target of $15
Oppenheimer analyst Les Sulewski initiates coverage on Cormedix (NASDAQ:CRMD) with a Outperform rating and announces Price Target of $15.
09-23 18:31
美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
RBC Capital Maintains Outperform on Cormedix, Raises Price Target to $14
RBC Capital analyst Leonid Timashev maintains Cormedix (NASDAQ:CRMD) with a Outperform and raises the price target from $13 to $14.
08-14 23:26
CorMedix Stock Jumps on Strong DefenCath Sales
CorMedix Inc. (NASDAQ:CRMD) shares are rising on Thursday after the company reported strong second-quarter results. The broader market was also slightly higher, with S&P 500 futures up 0.2%. The biopharmaceutical company reported adjusted earnings of 29 cents per share, topping the 25-cent consensus...
08-13 22:56
Accelerant Holdings, CorMedix, Birkenstock And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining around 200 points on Thursday. Shares of Accelerant Holdings (NYSE:ARX) rose sharply after the specialty insurance company agreed to be acquired by Thoma Bravo and reported better-than-expected second-quarter 2026 results. Second-quarter rev...
08-13 21:57
Full Transcript: Cormedix Q2 2026 Earnings Call
On Thursday, Cormedix (NASDAQ:CRMD) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts, visit https://www.benzinga.com/apis/. The full earnings call is ...
08-13 21:07
财报速睇 | CorMedix 2026财年Q2营收1.02亿美元，同比增长156.5%；归母净利润0.26亿美元，同比增长31.0%
华盛资讯8月13日讯，CorMedix公布2026财年Q2业绩，公司Q2营收1.02亿美元，同比增长156.5%，归母净利润0.26亿美元，同比增长31.0%。
08-13 20:17
财报速睇 | CorMedix 2026财年Q2营收1.02亿美元，同比增长156.5%；归母净利润0.26亿美元，同比增长31.1%
华盛资讯8月13日讯，CorMedix公布2026财年Q2业绩，公司Q2营收1.02亿美元，同比增长156.5%，归母净利润0.26亿美元，同比增长31.1%。
08-13 19:49
CorMedix rises after reporting Q3 results
CorMedix press release (CRMD): Q2 GAAP EPS of $0.29 beats by $0.05. Revenue of $101.93M (+156.5% Y/Y) beats by $5.88M. The Company maintains full-year 2026 consolidated revenue guidance of $325 to $34...
08-13 19:34
